Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | PZ75H | — |
Administration of expired dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number PZ75H, expiry date 28-FEB-2025) for prophylaxis. On 04-MAR-2025, the patient received Menveo. On 04-MAR-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Administration of expired dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 12-MAR-2025 Licensed practical nurse mentioned that administered a dose of Menveo 1 vial to a patient on 04th March 2025 and the dose expired on 28th February 2025 which led to expired vaccine use. Wanted to know if they should repeat the dose?